Clinical Trial Update: STOP Study: Effectiveness of Zyban in a Clinical Population [Phase 4]

View source ↗

Summary

Phase 4 STOP Study evaluated the effectiveness of Zyban (bupropion) for smoking cessation in a clinical population; results were posted in March 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Zyban (bupropion)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Cigarette Smoking, Nicotine Addiction | Phase 4 | Status: COMPLETED | Results posted: 2017-03-27